ALERS.PA
Eurobio Scientific Société anonyme
ParisEUREQUITY
Healthcare
DELAYED
Last price
19.90
▼ 0.50 (2.45%)
MARKET · —
Price
Too many bars for candle bodies at this width — showing high/low range per bar. Zoom in or pick a shorter range.
Open
20.50
Prev close
20.40
Day high
20.50
Day low
19.90
Volume
572
Market cap
$200.36M
P/E (TTM)
42.34
52W range
19.30 – 25.70
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
0
Total on file
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Trailing performance
Returnvs SPY
1W
-4.33%
-3.0%
1M
-5.69%
-9.4%
3M
-7.44%
-10.5%
6M
-10.96%
-22.0%
YTD
-18.28%
-30.6%
1Y
-21.03%
-41.0%
3Y
+26.43%
-47.7%
5Y
+15.23%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$200.36M
Enterprise value$195.70M
Revenue (TTM)$168.60M
Gross profit$76.84M
EBITDA$22.44M
Net income$4.87M
EPS (TTM)$0.47
Free cash flow$6.30M
Total cash$20.66M
Total debt$16.00M
Book value / share$18.27
Shares outstanding10.07M
Float843.62K
Short % of float—
Dividend yield—
Beta (5Y)0.70
Valuation & profitability ratios
Trailing P/E42.34
Forward P/E17.61
PEG ratio—
Price / sales—
Price / book1.09
EV / revenue1.16
EV / EBITDA8.72
Gross margin45.58%
Operating margin5.57%
Profit margin2.89%
Return on equity2.68%
Return on assets2.61%
Debt / equity8.70
Current ratio2.64
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $168.59M | $154.56M | $130.00M | $152.61M | +9.1% |
| Operating revenue | $168.59M | $154.56M | $130.65M | $152.90M | +9.1% |
| Cost of revenue | $91.75M | $82.99M | $73.16M | $81.66M | +10.6% |
| Gross profit | $76.84M | $71.57M | $56.84M | $70.95M | +7.4% |
| Research & development | $4.62M | $4.64M | $5.91M | $3.47M | -0.5% |
| Selling, general & admin | $52.99M | $45.46M | $33.52M | $31.00M | +16.6% |
| Total operating expense | $66.10M | $61.77M | $46.70M | $40.08M | +7.0% |
| Operating income | $10.74M | $9.79M | $10.14M | $30.87M | +9.7% |
| Net interest income | -$1.72M | -$2.82M | -$2.47M | -$1.18M | +39.1% |
| Pre-tax income | $7.81M | $6.28M | $6.98M | $29.68M | +24.3% |
| Tax provision | $2.94M | $2.29M | $2.14M | $4.75M | +28.6% |
| Net income | $4.87M | $4.00M | $4.83M | $24.94M | +21.7% |
| Net income to common | $4.87M | $4.00M | $4.83M | $24.94M | +21.7% |
| Basic EPS | 0.47 | 0.39 | 0.43 | 2.20 | +20.5% |
| Diluted EPS | 0.47 | 0.39 | 0.43 | 2.20 | +20.5% |
| EBIT | $9.74M | $10.41M | $11.33M | $30.95M | -6.4% |
| EBITDA | $26.68M | $27.46M | $25.58M | $40.17M | -2.8% |
| Basic shares | 10.25M | 10.25M | 11.15M | 11.34M | 0.0% |
| Diluted shares | 10.25M | 10.25M | 11.22M | 11.38M | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $20.32M | $21.77M | $49.30M | $47.49M | -6.7% |
| Cash & short-term investments | $20.66M | $23.07M | $89.03M | $85.94M | -10.4% |
| Accounts receivable | $34.09M | $32.73M | $26.94M | $32.78M | +4.2% |
| Inventory | $28.63M | $26.92M | $21.45M | $21.65M | +6.4% |
| Total current assets | $91.58M | $89.59M | $143.91M | $148.69M | +2.2% |
| Property, plant & equipment | $12.63M | $12.77M | $12.30M | $12.66M | -1.1% |
| Goodwill & intangibles | $151.49M | $153.52M | $153.13M | $154.98M | -1.3% |
| Total assets | $256.76M | $257.17M | $316.33M | $330.73M | -0.2% |
| Total current liabilities | $46.24M | $41.35M | $52.88M | $57.32M | +11.8% |
| Current debt | $2.25M | $725.00K | $13.28M | $13.73M | +209.7% |
| Long-term debt | $7.89M | $9.77M | $81.90M | $95.00M | -19.3% |
| Total debt | $16.02M | $34.05M | $101.33M | $114.31M | -53.0% |
| Total liabilities | $72.83M | $78.31M | $141.16M | $157.75M | -7.0% |
| Shareholder equity | $183.92M | $178.85M | $175.17M | $172.98M | +2.8% |
| Working capital | $45.34M | $48.23M | $91.03M | $91.37M | -6.0% |
| Net tangible assets | $32.44M | $25.33M | $22.04M | $18.00M | +28.0% |
| Shares issued | 10.25M | 10.25M | 10.94M | 11.34M | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $4.87M | $4.00M | $4.83M | $24.94M | +21.7% |
| Depreciation & amortisation | $16.94M | $17.05M | $14.25M | $9.22M | -0.7% |
| Change in working capital | -$4.24M | -$4.30M | $8.35M | $8.84M | +1.3% |
| Operating cash flow | $18.85M | $16.70M | $26.77M | $43.07M | +12.9% |
| Capital expenditure | -$12.57M | -$3.26M | -$4.05M | -$2.83M | -286.0% |
| Investing cash flow | -$12.89M | -$10.74M | -$318.00K | -$141.76M | -20.1% |
| Share buybacks | $0 | -$149.00K | -$2.79M | -$12.24M | +100.0% |
| Financing cash flow | -$8.16M | -$72.09M | -$23.50M | $82.31M | +88.7% |
| Free cash flow | $6.28M | $13.45M | $22.71M | $40.24M | -53.3% |
| End cash position | $20.66M | $23.07M | $89.03M | $85.94M | -10.4% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
| Line item | 2025-12-31 | 2024-12-31 | YoY |
|---|---|---|---|
| Cash & equivalents | $20.32M | $21.77M | -6.7% |
| Cash & short-term investments | $20.66M | $23.07M | -10.4% |
| Accounts receivable | $34.09M | $32.73M | +4.2% |
| Inventory | $28.63M | $26.92M | +6.4% |
| Total current assets | $91.58M | $89.59M | +2.2% |
| Property, plant & equipment | $12.63M | $12.77M | -1.1% |
| Goodwill & intangibles | $151.49M | $153.52M | -1.3% |
| Total assets | $256.76M | $257.17M | -0.2% |
| Total current liabilities | $46.24M | $41.35M | +11.8% |
| Current debt | $2.25M | $725.00K | +209.7% |
| Long-term debt | $7.89M | $9.77M | -19.3% |
| Total debt | $16.02M | $34.05M | -53.0% |
| Total liabilities | $72.83M | $78.31M | -7.0% |
| Shareholder equity | $183.92M | $178.85M | +2.8% |
| Working capital | $45.34M | $48.23M | -6.0% |
| Net tangible assets | $32.44M | $25.33M | +28.0% |
| Shares issued | 10.25M | 10.25M | 0.0% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | 1.13 | 1 | $175.90M | +4.7% |
| Next year | — | — | $0 | — |
Analyst targets & ownership
Mean target$30.00
High target$30.00
Low target$30.00
Implied upside50.75%
Analyst count1
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders0.00%
Held by institutions90.90%
Institutions holding2
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
20.60
-3.40% from price
SMA 20
20.84
-4.53% from price
SMA 50
21.26
-6.39% from price
SMA 100
21.99
-9.50% from price
SMA 200
22.84
-12.89% from price
EMA 12
20.60
-3.39% from price
EMA 26
20.86
-4.62% from price
EMA 50
21.21
-6.18% from price
RSI (14)
36.0
Neutral
MACD (12,26,9)
-0.27
Hist -0.07
ATR (14)
0.58
2.91% of price
Realised vol 30D
33.8%
Annualised
Bollinger upper
21.73
20, 2σ
Bollinger lower
19.96
20, 2σ
50 / 200 cross
Death
21.26 vs 22.84
Trend bias
Below 200
-12.89%
Risk profile
Beta vs SPY
0.18
Less volatile than market
Correlation to SPY
0.08
Largely independent
Realised vol 30D
33.8%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-22.3%
Peak to trough
Max drawdown 5Y
-56.0%
Peak to trough
ATR 14
0.58
2.91% of price
Beta (reported)
0.70
5Y monthly, from filing
Dividends & splits
Forward rate—
Forward yield—
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split1:20
Split dateSep 1, 2017
Headlines
Don’t Sell SanDisk Corporation (NASDAQ:SNDK) Because A Billionaire Did So, Says Jim Cramer
Insider Monkey · 17m ago
Jim Cramer Wasn’t Happy About Chevron Corporation (NYSE:CVX) Price Target Cut
Insider Monkey · 19m ago
$5,000 in Bloom Energy at Its COVID-Era Low Would Be Worth This Much Now
Motley Fool · 20m ago
Jim Cramer Wants You To Look At The Bigger Picture For Apple Inc. (NASDAQ:AAPL)
Insider Monkey · 21m ago
Jim Cramer Said NVIDIA Corp. (NASDAQ:NVDA) Doesn’t Need Anyone But Elon Musk
Insider Monkey · 22m ago
Jim Cramer Shared Insights Into Space Exploration Technologies Corp. (NASDAQ:SPCX) Short Selling
Insider Monkey · 23m ago
International Strength Offsetting North America Weakness Could Be A Game Changer For Under Armour (UAA)
Simply Wall St. · 24m ago
Jim Cramer Argued It’s A New World For Palo Alto Networks & CrowdStrike Holdings
Insider Monkey · 28m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.